Effects of probiotics and prebiotics in ulcerative colitis

Bratislava Medical Journal

Volumn 114, Issue 9, 2013, Pages 540-543

  Hijova, E ^a   Soltesova, A ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Nutrition; Prebiotics; Probiotics; Ulcerative colitis

Indexed keywords

PREBIOTIC AGENT; PROBIOTIC AGENT;

HUMAN; REVIEW; ULCERATIVE COLITIS;

COLITIS, ULCERATIVE; HUMANS; PREBIOTICS; PROBIOTICS;

EID: 84884311878     PISSN: 00069248     EISSN: 13360345     Source Type: Journal    
DOI: 10.4149/BLL_2013_113     Document Type: Review

References (26)

1. Bibiloni R, Fedorak RN, Tannock GW, Madsen KI, Gionchetti P, Campieri M, De SC, Sartor RB. VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-1546.
2. Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin, ME. Probiotics and imunity. J Gastroenterol 2009; 44: 659-664.
3. Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, Liu YH, Dan HL, Jian YT, Chen XQ. Effects of probiotic on intestinal mucisa of patients with ulcerative colitis. World J Gastroenterol 2004; 10: 1521-1525.
4. Čierna I, Szépeová R, Valachová I, Majorová E. Výskyt Crohnovej choroby a ulceróznej kolitídy v detskej populácii na Slovensku. Gastroenterol. Prax 2008; 7: 101-106.
5. Diba ChS, Pleško I, Hlava P (Eds). Cancer incidence in the Slovak Republic. Bratislava; NCZI, 2010.
6. Fedorak RN, Madsen KL. Probiotics and the management of infl ammatory bowel disease. Infl amm Bowel Dis 2004; 10: 286-299.
7. Furrie E, Macfarlane S, Kennedy A, Cumming JH, Walsh SV, Óneil DA, Macfarlane GT. Synbiotic therapy (Bifi dobacterium longum/Synergy 1) initiates resolution of infl ammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 2005; 54: 242-249.
8. Gibson GR, Probert HM, Loo JV, Rastall RA, Roberfoid MB. Dietary modulation of the human colonic microbiota: updating the concept of prebiotics. Nutr Res Rev 2004; 17: 259-275.
9. Guarner F. Prebiotics in infl ammatory bowel diseases. Br J Nutr 2007; 98 (Suppl 1): 85-89.
10. Greguš M. Ulcerózna kolitída. 354-368. In: Jurgoš L, Kužela L, Hrušovský Š (Eds). Gastroenterológia. Bratislava; Veda, 2006.
11. Grimoud J, Duran H, de Souza S, Monsan P, Ouarné F, Theodorou V, Roques Ch. In vitro screening of probiotics and synbiotics according to anti-infl ammatory and anti-proliferative effects. Int J Food Microbiol 2010; 144: 42-50.
12. Hedin C, Whelan K, Lindsay JO. Evidence for the use of probiotics and prebiotics in infl ammatory bowel disease: a review of clinical trials. Proc Nutr Soc 2007; 66: 307-315.
13. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifi dobacteria-fermented milk on ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63.
14. Kanneganti M, Mino-Kenuson M, Mizoguchi E. Animal models of colitis-associated carcinogenesis. J Biomed Biotechnol 2011; 2011: ID 342637, 23 pp, doi:10.1155/2011/342637
15. Kato K, Mizuno S, Umesaki Y, Ishii Y, Sugitani M, Imaoka A, Otsuka M, Hasunuma O, Kurihana R, Iwasaki A, Arakawa Y. Randomised placebo-controlled trial assessing the effect of bifi dobacteriafermented milk on active ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1133-1141.
16. Kruis W, Fric P, Pokrotnieks J, Lukas M, Fixa B, Kascak M, Kamm MA, Weismueller J, Beglinger C, Stolte M, Wolff C, Schulze J. Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine. Gut 2004; 53: 1617-1623.
17. Leenen CH, Dieleman LA. Inulin and oligofructose in chronic infl ammatory bowel disease. J Nutr 2007; 137 (Suppl 11): 2572S-2575S.
18. Looijer-van Langen MA, Dieleman LA. Prebiotics in chronic intestinal infl ammation. Infl amm Bowel Dis 2009; 15: 454-462.
19. Rembacken BJ, Snelling AM, Hawkey PM, Chalmers DM, Axon AT. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet 1999; 354: 635-639.
20. Report on population health in Slovak Republic for the years 2006-2008. www.zdravie.sk/sz/content
21. Rolle DR. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000; 130: 396S-402S.
22. Salminen S, Ouwehand AC, Isolauri E. Clinical applications of probiotic bacteria. Int Dairy J 1998; 8: 563-572.
23. Tursi A, Brandimarte G, Giorgetti GM, Forti G, Modeo ME, Gigliobianco A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med Sci Monit 2004; 10: PI126-PI131.
24. Venturi A, Gionchetti P, Rizzello F, Johansson R, Zucconi E. Brigidi P, Matteuzzi D, Campieri M. Impact on the composition of the faecal fl ora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103-1108.
25. Xia Y, Chen HQ, Zhang M, Jiang YQ, Hang XM, Qin HL. Effect of Lactobacillus plantarum LP-Onlly on the gut fl ora and colitis in interleukin- 10 knockout mice. J Gastroenterol Hepatol 2011; 26: 405-411.
26. Zocco MA, dal Verme LZ, Cremonini F, Piscaglia AC, Nista EC, Candelli M, Novi M, Rigante D, Cazzano IA, Ojetti V, Armuzzi A, Gasbarrini G, Gasbarrini A. Effi cacy of Lactobacillus GG in maintaining remission of ulceraive colitis. Aliment Pharmacol Ther 2006; 23: 1567-1574.